{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06033222",
            "orgStudyIdInfo": {
                "id": "23-003520"
            },
            "organization": {
                "fullName": "Mayo Clinic",
                "class": "OTHER"
            },
            "briefTitle": "A Study of Perturbation of Human Small Intestinal Colonic Permeability",
            "officialTitle": "Developing an Approach to Perturbation of Human Small Intestinal and Colonic Permeability in Healthy Participants",
            "therapeuticArea": [
                "Other"
            ],
            "study": "a-study-of-perturbation-of-human-small-intestinal-colonic-permeability"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-01-08",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-05-23",
                "type": "ACTUAL"
            },
            "completionDateStruct": {
                "date": "2024-07-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-09-05",
            "studyFirstSubmitQcDate": "2023-09-05",
            "studyFirstPostDateStruct": {
                "date": "2023-09-13",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-06-10",
            "lastUpdatePostDateStruct": {
                "date": "2024-06-12",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Michael Camilleri, MD",
                "investigatorTitle": "Principal Investigator",
                "investigatorAffiliation": "Mayo Clinic"
            },
            "leadSponsor": {
                "name": "Mayo Clinic",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": true
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to evaluate the effect of castor oil versus placebo on intestinal permeability in healthy individuals.",
            "detailedDescription": "Randomized, parallel-group, placebo-controlled, blinded, dose-response study using Castor oil and see the effects it has on small bowel and colonic permeability measured in healthy female and male adults."
        },
        "conditionsModule": {
            "conditions": [
                "Healthy"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "EARLY_PHASE1"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "interventionModelDescription": "Prospective randomized, placebo-control study of effect of castor oil on intestinal and colonic permeability",
                "primaryPurpose": "OTHER",
                "maskingInfo": {
                    "masking": "DOUBLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "INVESTIGATOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 24,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "750 mg castor oil treatment group",
                    "type": "EXPERIMENTAL",
                    "description": "Subjects will take ricinoleic acid daily on an empty stomach in the morning 30 minutes before breakfast for a total of 4 days",
                    "interventionNames": [
                        "Dietary Supplement: Ricinoleic Acid 750 mg"
                    ]
                },
                {
                    "label": "1500 mg castor oil treatment group",
                    "type": "EXPERIMENTAL",
                    "description": "Subjects will take ricinoleic acid daily on an empty stomach in the morning 30 minutes before breakfast for a total of 4 days",
                    "interventionNames": [
                        "Dietary Supplement: Ricinoleic Acid 1500 mg"
                    ]
                },
                {
                    "label": "3000 mg castor oil treatment group",
                    "type": "EXPERIMENTAL",
                    "description": "Subjects will take ricinoleic acid daily on an empty stomach in the morning 30 minutes before breakfast for a total of 4 days",
                    "interventionNames": [
                        "Dietary Supplement: Ricinoleic Acid 3000 mg"
                    ]
                },
                {
                    "label": "Placebo group",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Subjects will take placebo daily on an empty stomach in the morning 30 minutes before breakfast for a total of 4 days",
                    "interventionNames": [
                        "Drug: Placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DIETARY_SUPPLEMENT",
                    "name": "Ricinoleic Acid 750 mg",
                    "description": "750 mg administered orally",
                    "armGroupLabels": [
                        "750 mg castor oil treatment group"
                    ]
                },
                {
                    "type": "DIETARY_SUPPLEMENT",
                    "name": "Ricinoleic Acid 1500 mg",
                    "description": "1500 mg administered orally",
                    "armGroupLabels": [
                        "1500 mg castor oil treatment group"
                    ]
                },
                {
                    "type": "DIETARY_SUPPLEMENT",
                    "name": "Ricinoleic Acid 3000 mg",
                    "description": "3000 mg administered orally",
                    "armGroupLabels": [
                        "3000 mg castor oil treatment group"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebo",
                    "description": "Contains no active ingredient.",
                    "armGroupLabels": [
                        "Placebo group"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Change in urinary excretion of 13^C-mannitol",
                    "description": "Percent urinary excretion of 13\\^C-mannitol",
                    "timeFrame": "0-2 hours, 2-8 hours and 8-24 hours"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change in urinary excretion of lactulose",
                    "description": "Percent urinary excretion of lactulose",
                    "timeFrame": "0-2 hours, 2-8 hours and 8-24 hours"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Healthy, non-obese, non-pregnant volunteers.\n* 1:1 Male/Female Ratio.\n* BMI \\< 30 kg/m\\^2.\n\nExclusion Criteria:\n\n* Diabetes.\n* Uncontrolled hypertension (with BP measured \\> 140/90mmHg in the CRTU)\n* BMI \u2265 30 kg/m\\^2.\n* Chronic NSAID use (\\> 1 day/week).\n* Use of oral antibiotics for 2 weeks prior to and during the entire 5 day study period.\n* Known intolerance of castor oil.\n* Diagnosis of gastrointestinal diseases that are associated with abnormal intestinal or colonic permeability such as inflammatory bowel diseases, irritable bowel syndrome and celiac disease.\n* Prior intestinal or colonic resection.\n* Participation in highly vigorous exercise such as running \\> 5 miles per day in week prior to the permeability test.",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "70 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "overallOfficials": [
                {
                    "name": "Michael Camilleri, MD",
                    "affiliation": "Mayo Clinic",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Mayo Clinic Minnesota",
                    "status": "RECRUITING",
                    "city": "Rochester",
                    "state": "Minnesota",
                    "zip": "55905",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Deb Eckert, RN",
                            "role": "CONTACT",
                            "phone": "507-538-5860",
                            "email": "eckert.deborah@mayo.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.02163,
                        "lon": -92.4699
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M5620",
                    "name": "Castor Oil",
                    "relevance": "LOW"
                },
                {
                    "id": "T120",
                    "name": "Cola",
                    "relevance": "LOW"
                },
                {
                    "id": "T94",
                    "name": "Castor",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Gast",
                    "name": "Gastrointestinal Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "HB",
                    "name": "Herbal and Botanical"
                }
            ]
        }
    },
    "hasResults": false
}